Literature DB >> 11672546

TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice.

E N Tsitsikov1, D Laouini, I F Dunn, T Y Sannikova, L Davidson, F W Alt, R S Geha.   

Abstract

TNF receptor-associated factor 1 (TRAF1) is a unique TRAF protein because it lacks a RING finger domain and is predominantly expressed in activated lymphocytes. To elucidate the function of TRAF1, we generated TRAF1-deficient mice. TRAF1(-/-) mice are viable and have normal lymphocyte development. TRAF1(-/-) T cells exhibit stronger than wild-type (WT) T cell proliferation to anti-CD3 mAb, which persisted in the presence of IL-2 or anti-CD28 antibodies. Activated TRAF1(-/-) T cells, but not TRAF1(+/+) T cells, responded to TNF by proliferation and activation of the NF-kappa B and AP-1 signaling pathways. This TNF effect was mediated by TNFR2 (p75) but not by TNFR1 (p55). Furthermore, skin from TRAF1(-/-) mice was hypersensitive to TNF-induced necrosis. These findings suggest that TRAF1 is a negative regulator of TNF signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672546     DOI: 10.1016/s1074-7613(01)00207-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  66 in total

1.  The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.

Authors:  Cory Ahonen; Eric Manning; Loren D Erickson; Brian O'Connor; Evan F Lind; Steven S Pullen; Marilyn R Kehry; Randolph J Noelle
Journal:  Nat Immunol       Date:  2002-04-22       Impact factor: 25.606

2.  TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.

Authors:  Aristides G Eliopoulos; Elyse R Waites; Sarah M S Blake; Clare Davies; Paul Murray; Lawrence S Young
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Comparison of the peptide binding preferences of three closely related TRAF paralogs: TRAF2, TRAF3, and TRAF5.

Authors:  Glenna Wink Foight; Amy E Keating
Journal:  Protein Sci       Date:  2016-02-03       Impact factor: 6.725

4.  The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Atsuko Asao; Takeshi Kawabe; Satoshi Yamaki; Hiroyasu Nakano; Michael Croft; Naoto Ishii; Takanori So
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606

5.  A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival.

Authors:  Laurent Sabbagh; Cathy C Srokowski; Gayle Pulle; Laura M Snell; Bradley J Sedgmen; Yuanqing Liu; Erdyni N Tsitsikov; Tania H Watts
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

6.  Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.

Authors:  Katy Derbyshire; Caroline Addey; David Coe; Daniel W Stuckey; Hasan Muezzin; Jason A Bubier; Daniel J Shaffer; Derry C Roopenian; Jian-Guo Chai; Diane M Scott
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

7.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

8.  The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death.

Authors:  Seung-Joo Lee; Meixiao Long; Adam J Adler; Robert S Mittler; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2008-10-15       Impact factor: 4.962

Review 9.  Function of tumor necrosis factor receptor family members on regulatory T-cells.

Authors:  Robert H Arch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

10.  Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal.

Authors:  Jing Yao Leong; Phyllis Chen; Joo Guan Yeo; Fauziah Ally; Camillus Chua; Sharifah Nur Hazirah; Su Li Poh; Lu Pan; Liyun Lai; Elene Seck Choon Lee; Loshinidevi D/O Thana Bathi; Thaschawee Arkachaisri; Daniel Lovell; Salvatore Albani
Journal:  Ann Rheum Dis       Date:  2019-09-20       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.